Devon Gessert

8.8k total citations · 1 hit paper
9 papers, 467 citations indexed

About

Devon Gessert is a scholar working on Physiology, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, Devon Gessert has authored 9 papers receiving a total of 467 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Physiology, 4 papers in Psychiatry and Mental health and 2 papers in Molecular Biology. Recurrent topics in Devon Gessert's work include Dementia and Cognitive Impairment Research (4 papers), Alzheimer's disease research and treatments (4 papers) and Functional Brain Connectivity Studies (2 papers). Devon Gessert is often cited by papers focused on Dementia and Cognitive Impairment Research (4 papers), Alzheimer's disease research and treatments (4 papers) and Functional Brain Connectivity Studies (2 papers). Devon Gessert collaborates with scholars based in United States, Sweden and Netherlands. Devon Gessert's co-authors include Michael S. Rafii, Robert A. Rissman, Rema Raman, Michael Donohue, James B. Brewer, Tiffany W. Chow, Paul Aisen, Suzanne Craft, Cecily Jenkins and Chung‐Kai Sun and has published in prestigious journals such as Journal of Alzheimer s Disease, Frontiers in Neuroscience and JAMA Neurology.

In The Last Decade

Devon Gessert

8 papers receiving 464 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia

2020 266 citations Suzanne Craft, Rema Raman et al. JAMA Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Devon Gessert United States	5	261	102	90	83	73	9	467
Hailin Lu China	7	299 1.1×	69 0.7×	127 1.4×	34 0.4×	47 0.6×	16	514
Pierluigi Sebastiani Italy	12	182 0.7×	80 0.8×	178 2.0×	40 0.5×	38 0.5×	28	586
J. O’Grady United Kingdom	12	199 0.8×	152 1.5×	127 1.4×	129 1.6×	45 0.6×	29	742
Tadafumi C. Ikezu United States	6	246 0.9×	120 1.2×	147 1.6×	66 0.8×	30 0.4×	6	453
Pamela V. Martino Adami Argentina	13	207 0.8×	70 0.7×	175 1.9×	41 0.5×	21 0.3×	20	436
Tomokazu Shimazu Japan	12	132 0.5×	146 1.4×	205 2.3×	69 0.8×	23 0.3×	29	531
Beth Safirstein United States	8	331 1.3×	94 0.9×	98 1.1×	79 1.0×	112 1.5×	18	630
Sophia Raefsky United States	9	215 0.8×	62 0.6×	193 2.1×	15 0.2×	25 0.3×	13	546
Ana‐Caroline Raulin United States	6	268 1.0×	123 1.2×	176 2.0×	61 0.7×	41 0.6×	8	514
Jordan B. Jahrling United States	10	414 1.6×	227 2.2×	252 2.8×	38 0.5×	84 1.2×	10	747

Countries citing papers authored by Devon Gessert

Since Specialization

Citations

This map shows the geographic impact of Devon Gessert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Devon Gessert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Devon Gessert more than expected).

Fields of papers citing papers by Devon Gessert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Devon Gessert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Devon Gessert. The network helps show where Devon Gessert may publish in the future.

Co-authorship network of co-authors of Devon Gessert

This figure shows the co-authorship network connecting the top 25 collaborators of Devon Gessert. A scholar is included among the top collaborators of Devon Gessert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Devon Gessert. Devon Gessert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Insel, Philip S., Meryl A. Butters, Ruth Morin, et al.. (2021). The Impact of Amyloid Burden and APOE on Rates of Cognitive Impairment in Late Life Depression. Journal of Alzheimer s Disease. 80(3). 991–1002. 14 indexed citations

2.

Walter, Sarah, Suzanne Craft, David Geldmacher, et al.. (2021). Utilizing study and site performance metrics to improve efficiency of clinical trials: An initiative of the Alzheimer’s Clinical Trials Consortium (ACTC). Alzheimer s & Dementia. 17(S9). 1 indexed citations

3.

Ngolab, Jennifer, Michael Donohue, Jennifer Salazar, et al.. (2021). Feasibility study for detection of retinal amyloid in clinical trials: The Anti‐Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) trial. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 13(1). e12199–e12199. 22 indexed citations

4.

Craft, Suzanne, Rema Raman, Tiffany W. Chow, et al.. (2020). Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia. JAMA Neurology. 77(9). 1099–1099. 266 indexed citations breakdown →

5.

Dyck, Christopher H. van, Haakon B. Nygaard, Kewei Chen, et al.. (2019). Effect of AZD0530 on Cerebral Metabolic Decline in Alzheimer Disease. JAMA Neurology. 76(10). 1219–1219. 107 indexed citations

6.

Craft, Suzanne, Rema Raman, Tiffany W. Chow, et al.. (2019). DT‐02‐03: OPEN LABEL EXTENSION RESULTS FROM A PHASE II/III TRIAL OF INTRANASAL INSULIN. Alzheimer s & Dementia. 15(7S_Part_28). 2 indexed citations

7.

Insel, Philip S., Rik Ossenkoppele, Devon Gessert, et al.. (2017). Time to Amyloid Positivity and Preclinical Changes in Brain Metabolism, Atrophy, and Cognition: Evidence for Emerging Amyloid Pathology in Alzheimer's Disease. Frontiers in Neuroscience. 11. 281–281. 54 indexed citations

8.

Insel, Philip S., Sebastian Palmqvist, Scott Mackin, et al.. (2016). P1‐338: Assessing Risk for Preclinical β‐Amyloid Pathology with APOE, Cognitive and Demographic Information. Alzheimer s & Dementia. 12(7S_Part_11).

9.

Relkin, Norman, Devon Gessert, Leock Y. Ngo, et al.. (2012). O3‐13‐05: The Gammaglobulin Alzheimer Partnership Study (GAP): Design, screening, enrollment and futility analysis results. Alzheimer s & Dementia. 8(4S_Part_12). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact